When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions FDA mulls compounding for peptides previously flagged over safety risks BioSpace Is BPC 157 Banned? Oral vs. Injectable Forms Explained Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York